00:22 , Jul 6, 2007 |  BC Extra  |  Financial News

BioInvent raises $18.3 million

BioInvent (SSE:BINV) raised SEK125.4 million ($18.3 million) in a direct offering of 8.5 million shares at SEK14.75 per share, which is a 1% discount to BINV's close of SEK14.95 on June 18, the day before...
01:32 , Jun 20, 2007 |  BC Extra  |  Financial News

BioInvent to raise $17.8 million

BioInvent (SSE:BINV) said it plans to raise SEK125.4 million ($17.8 million) in a direct offering of 8.5 million shares at SEK14.75 per share, which is a 1% discount to BINV's close of SEK14.95 on Monday....
07:00 , May 28, 2007 |  BioCentury  |  Finance

Adding up Addex

Buysiders were clearly split on the pricing of the Addex IPO on the SWX Swiss Exchange last week. Despite being more than four times over-subscribed, the stock - which priced last Monday at CHF73 a...
01:05 , May 23, 2007 |  BC Extra  |  Financial News

QuatRx raises $44 million

QuatRx (Ann Arbor, Mich.) raised $44 million in a series E round led by new investor Venrock. T. Rowe Price; Catella; and Hercules Technology Growth Capital, also new investors, joined existing investors Frazier Healthcare Ventures;...
00:21 , May 12, 2007 |  BC Extra  |  Financial News

Karo Bio raises $60.2 million

Karo Bio (SSE:KARO) raised SEK406 million ($60.2 million) in a rights issue through the sale of 38.7 million shares at SEK10.50. The price is a 42% discount to KARO's close of SEK18 on March 26,...
07:00 , Jun 5, 2006 |  BioCentury  |  Finance

Ebb & Flow

But investors keep returning. This quarter, ISIS has attracted both a new face ( Symphony Capital ) and a familiar one ( Acqua ) to its story. Both investors say their due diligence suggests a...
00:50 , Jun 1, 2006 |  BC Extra  |  Financial News

Curalogic prices IPO

Curalogic (Copenhagen, Denmark) raised DKK187.5 million ($32.1 million) through the sale of 2.5 million shares at DKK75 in an IPO coordinated by Danske Bank. Private investors Danish Labour Market Supplementary Pension Fund; Catella; Faamandsforeningen LD;...
00:25 , May 23, 2006 |  BC Extra  |  Financial News

Curalogic updates IPO plans

Curalogic (Copenhagen, Denmark) updated its IPO plans and now expects to raise DKK187.5 million ($32.1 million) through the sale of 2.5 million shares at DKK75. Last week, the company proposed to raise about DKK200 million...
07:00 , Oct 18, 2004 |  BioCentury  |  Finance

Ebb & Flow

Investors in PharmAthene's $50 million series B round are betting that there's more than the conventional cost-plus 10% in government biodefense contracts. PharmAthene, which is essentially a biodefense play, has an anthrax therapeutic in preclinical...